People: Bayer AG (BAYZF.PK)

BAYZF.PK on OTC Markets Group

140.00USD
30 Oct 2014
Price Change (% chg)

$4.00 (+2.94%)
Prev Close
$136.00
Open
$138.05
Day's High
$140.00
Day's Low
$138.05
Volume
391
Avg. Vol
1,176
52-wk High
$145.50
52-wk Low
$123.55

Search Stocks

Summary

Name Age Since Current Position

Werner Wenning

67 2012 Chairman of the Supervisory Board

Marijn Dekkers

56 2010 Chairman of the Management Board, Chief Executive Officer

Hermann Strenger

Honorary Chairman of the Supervisory Board

Thomas de Win

55 2006 Vice Chairman of the Supervisory Board

Johannes Dietsch

52 2014 Chief Financial Officer, Member of the Management Board

Michael Koenig

50 2013 Member of the Management Board responsible for Human Resources

Werner Baumann

51 2014 Member of the Management Board and Chief Strategy and Portfolio Officer

Kemal Malik

51 2014 Member of the Management Board responsible for Innovation and the North America region

Paul Achleitner

57 2002 Member of the Supervisory Board

Clemens Boersig

65 2007 Member of the Supervisory Board

Thomas Ebeling

55 2012 Member of the Supervisory Board

Thomas Fischer

58 2005 Member of the Supervisory Board

Peter Hausmann

60 2006 Member of the Supervisory Board

Reiner Hoffmann

58 2006 Member of the Supervisory Board

Yueksel Karaaslan

46 2012 Member of the Supervisory Board

Klaus Kleinfeld

56 2005 Member of the Supervisory Board

Petra Kronen

49 2000 Member of the Supervisory Board

Helmut Panke

67 2007 Member of the Supervisory Board

Sue Rataj

57 2012 Member of the Supervisory Board

Petra Reinbold-Knape

54 2012 Member of the Supervisory Board

Michael Schmidt-Kiessling

54 2012 Member of the Supervisory Board

Ekkehard Schulz

72 2005 Member of the Supervisory Board

Klaus Sturany

67 2007 Independent Member of the Supervisory Board

Andre van Broich

43 2012 Member of the Supervisory Board

Ernst-Ludwig Winnacker

72 1997 Member of the Supervisory Board

Oliver Zuehlke

45 2007 Member of the Supervisory Board

Alexander Rosar

Head of Investor Relations

Biographies

Name Description

Werner Wenning

Mr. Werner Wenning has been Chairman of the Supervisory Board of Bayer AG as of October 1, 2012. He is Chairman of Presidial and Mediation Committee, Nominations Committee and Human Resources Committee and Member of the Audit Committee at the Company. Prior to that he acted as Member of the Supervisory Board since April 27, 2012 and Chairman of the Management Board and Chief Executive Officer of the Company since April 26, 2002. Mr. Wenning is Chairman of the Supervisory Board of Bayer Schering Pharma AG. He joined Company in 1966 as a commercial trainee. He held a number of positions with Bayer in Germany and abroad, serving as managing director of Bayer subsidiaries in Peru and Spain and later as Head of the Corporate Planning and Controlling Division. Mr. Wenning was appointed to the Board of Management as Chief Financial Officer in February 1997. Since September 2005 he has also been President of the German Chemical Industry Association. Mr. Wenning is also Vice President of the Federation of German Industries and a Member of the Supervisory Board of Henkel KGaA and Evonik Industries AG.

Marijn Dekkers

Dr. Marijn E. Dekkers, PhD, has been Chairman of the Management Board and Chief Executive Officer of Bayer AG since October 1, 2010. He served as Member of the Management Board at the Company as of January 1, 2010. He began his career in the central research department of General Electric in Schenectady, New York. Two years later, Dr. Dekkers transferred to the GE Plastics research facility at Bergen op Zoom in the Netherlands. In 1988 he returned to the corporate research center to become Head of polymer materials research. After that, Dr. Dekkers held further management positions in various polymers units of GE. In 1995 he joined Allied Signal (subsequently Honeywell International Inc.) in Morristown, New Jersey. In the period through the end of 1999 he headed this company’s Specialty Films and Fluorine Chemicals business groups and then the Electronic Materials division in San Jose in California’s Silicon Valley. In 2000 Dr. Dekkers accepted an offer from Boston-based Thermo Electron Corporation. There he initially served as Chief Operating Officer. Two years later he was appointed the company’s President and Chief Executive Officer. Dr. Dekkers received a Bachelor degree in Chemistry from University of Nijmegen and a Master degree as well as a Doctorate in Chemistry from Technische Universiteit Eindhoven.

Hermann Strenger

Thomas de Win

Mr. Thomas de Win has been Vice Chairman of the Supervisory Board at Bayer AG since March 2, 2006. In addition, he acts as Member of the Company's Presidial and Mediation Committee as well as Audit Committee. Mr. de Win joined Bayer AG in 1974. From 1975 to 1978 he trained as an office management assistant. On completion of his vocational training Mr. de Win worked in the administration of Bayer AG. Between 1976 and 1984 he held various positions in the Central Representative Body for Young Workers and Trainees. After completing his civilian service (1980 to 1981), Mr. de Win became a Member of the Bayer AG Works Council in 1984. Since 1989 he has been released for service as a Works Council Member. In 1998 Mr. de Win was elected Deputy Chairman of the Works Council. Since that time he has been a Member of both the Central and Group Works Councils. One year later he became Deputy Chairman of the Bayer Central Works Council. In 2001 he was elected to the National Board of the German Mine, Chemical and Power Workers' Union. Mr. de Win is Chairman of the Bayer Group Works Council as well as Bayer Central Works Council. He is also Member of the Supervisory Board of Bayer MaterialScience AG.

Johannes Dietsch

Mr. Johannes Dietsch has been appointed Member of the Management Board and Chief Financial Officer at Bayer AG, effective October 1, 2014. He will be appointed to the Board of Management of Bayer AG effective September 1, 2014. After graduating from high school, he joined Bayer as a commercial trainee. On completion of his training in 1984, he held a number of management positions in various departments within the Company. He gained several years of overseas experience during two assignments at Bayer Japan, Ltd., latterly as Chief Financial Officer (CFO) in finance and administration. In 2001 Mr. Dietsch was made Head of Corporate Finance in the Finance Division, becoming Head of Finance in the Corporate Center of Bayer AG on July 1, 2002. His area of responsibility included Treasury, Corporate Finance, Financial Controlling, Asset Management Pensions, Mergers & Acquisitions and Taxes. In September 2011, he was appointed as Senior Bayer Representative and CFO for Greater China at Bayer China in Shanghai.

Michael Koenig

Mr. Michael Koenig has been Member of the Management Board responsible for Human Resources of Bayer AG since April 1, 2013. He is also responsible for the Latin America, Africa and Middle East regions and the subsidiary Currenta. After studying chemical process engineering at Technische Universitaet Dortmund and performing his compulsory military service, Mr. Koenig joined Bayer as a process engineer for chemicals projects in Europe. He assumed a variety of engineering-related positions of increasing responsibility in the areas of engineering, process development and maintenance management. He transferred to China in 2000 to become General Manager of Bayer Polymers Shanghai Co. Ltd. There he oversaw the construction of the new production site, the Bayer Integrated Site Shanghai, and was made site manager in 2002. Thereafter he served as Global Head of Production and Technology Isocyanates at Bayer Material Science. On April 1, 2007, Mr. Koenig became Senior Bayer Representative for the Greater China country group and Senior Country Representative for Bayer MaterialScience in China. He was Head of Bayer MaterialScience's Polycarbonate Business Unit from July 1, 2011, until his appointment to the Bayer Board of Management. He was also the member of the Bayer MaterialScience Executive Committee responsible for the Asia/Pacific region.

Werner Baumann

Mr. Werner Baumann has been appointed Member of the Management Board and Chief Strategy and Portfolio Officer at Bayer AG effective October 1, 2014. Prior to this, he has served as Member of the Management Board responsible for Finance at Bayer AG since May 1, 2010. After studying Economics at RWTH Aachen University and the University of Cologne, he joined Bayer AG in 1988. His first duties were in the Corporate Finance Department in Leverkusen. In 1991 Mr. Baumann transferred to Bayer Hispania Comercial in Barcelona, Spain, to take up a position as Controller, becoming Assistant to the Managing Director in 1995. A year later, he moved to Bayer Corporation in Tarrytown, New York, latterly heading up the global Business Planning and Administration organization of the Diagnostics Business Group. In July 2002, Mr. Baumann returned to Germany to become Member of the Executive Committee and Head of Central Administration and Organization at Bayer HealthCare. In October 2003 he was appointed Member of the Board of Management of the newly formed subgroup Bayer HealthCare AG, also serving as the company’s Labor Director. As Member of the Board of Management and Labor Director of Bayer Schering Pharma, Berlin, Germany, from 2006 through September 2009, he actively participated in this company’s integration into the subgroup. Until December 31, 2009 Mr. Baumann also served on the Board of Bayer Business Services GmbH and until March 31, 2009 he was active on the Board of DIREVO Biotech AG. Since May 1, 2010 Mr. Baumann also has been active as Chairman of the Board at Bayer Business Services GmbH and Bayer CropScience AG.

Kemal Malik

Dr. Kemal Malik is Member of the Management Board responsible for Innovation and the North America region at Bayer AG effective February 1, 2014. Dr. Malik spent several years in clinical medicine at the Northwick Park Clinical Research Centre and at Hammersmith Hospital, London. He then held various positions in medical affairs and clinical development at Bristol-Myers Squibb in the United Kingdom. Dr. Malik joined Bayer in 1995 as Head of Metabolism and Oncology Europe in the then Pharmaceuticals Business Group. He subsequently served as Head of Global Medical Development before being appointed Head of Global Development. He was a member of the Executive Committee of Bayer HealthCare AG from July 1, 2007 until his appointment to the Board of Management of Bayer AG. He was also Head of Global Development and Chief Medical Officer in the Pharmaceuticals Division. He studied medicine at Charing Cross and Westminster Medical School (University of London), graduating as a Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1987.

Paul Achleitner

Dr. Paul Achleitner has been Member of the Supervisory Board at Bayer AG since April 26, 2002. In addition, he acts as Member of the Company's Presidial and Mediation Committee as well as the Nomination and Human Resources Committees. Until February 7, 2008 Dr. Achleitner was Chairman of the Supervisory Board of Allianz Elementar Lebensversicherungs-AG and Allianz Elementar Versicherungs-AG, and Vice Chairman of the Supervisory Board of Allianz Investment Bank. He was Member of the Supervisory Board of Allianz Lebensversicherungs-AG until May 7, 2008. Until the end of June 2010 he served on the Supervisory Board of Allianz Deutschland AG. In addition, Dr. Achleitner is Member of the Supervisory Board of Allianz Global Investors AG, RWE AG and as of April 2010 also of Daimler AG. Furthermore, he occupies the position of Chairman of the Board of Directors at Allianz Investment Management SE. He holds a degree from Harvard University and earned a Doctorate in Philosophy degree from Universitaet St. Gallen.

Clemens Boersig

Dr. Clemens A. H. Boersig has been Member of the Supervisory Board at Bayer AG since April 2007. Dr. Boersig served as Member of the Supervisory Board of Deutsche Lufthansa AG until April 29, 2008. He occupies the position of Chairman of the Supervisory Board at Deutsche Bank AG. Furthermore, he serves on the Supervisory Board of Daimler AG, Linde AG as well as Emerson Electric Co. In 1973 he obtained a degree in Mathematics as well as Business Administration from Universitaet Mannheim (University of Mannheim). He also earned a Doctorate degree in Economics from Universitaet Mannheim in 1975.

Thomas Ebeling

Mr. Thomas Ebeling has been appointed Member of the Supervisory Board of Bayer AG with effect from April 27, 2012. He is Chairman of the Supervisory Board at ProSiebenSat.1 Media AG.

Thomas Fischer

Dr. Thomas Fischer has been Member of the Supervisory Board at Bayer AG since October 1, 2005. Additionally, he acts as Member of the Audit Committee of the Company. Dr. Fischer is Member of the Supervisory Board of Bayer MaterialScience AG and Chairman of the Group Managerial Employees’ Committee of Bayer AG.

Peter Hausmann

Mr. Peter Hausmann has been Member of the Supervisory Board at Bayer AG since April 28, 2006. In addition, he acts as Member of the Presidial and Mediation Committee of the Company. Until November 6, 2009 he was North Rhine District Secretary of the German Mine, Chemical and Industrial Union until November 6, 2009. Furthermore, he was Member of the Supervisory Board of Evonik Services GmbH until December 2011. Since October 13, 2009 Mr. Hausmann has served as Member of the Executive Committee of the German Mining, Chemical and Energy Industrial Union.

Reiner Hoffmann

Mr. Reiner Hoffmann has been Member of the Supervisory Board at Bayer AG since October 11, 2006. He is North Rhine District Secretary of the German Mining, Chemical and Energy Industrial Union. Furthermore, Mr. Hoffmann also serves as Member of the Supervisory Board at SASOL Germany GmbH and as of September 2010 also at Evonik Services GmbH. He is Member of the Audit Committee at the Company.

Yueksel Karaaslan

Mr. Yueksel Karaaslan has served as Member of the Supervisory Board of Bayer AG since April 27, 2012. He also acts as Chairman of the Works Council of the Berlin site of Bayer, Vice Chairman of the Bayer Central Works Council and Member of the Supervisory Board of Bayer Pharma AG.

Klaus Kleinfeld

Dr. Klaus Kleinfeld has been Member of the Supervisory Board at Bayer AG since April 29, 2005. Currently, Dr. Kleinfeld occupies the position of Chairman and Chief Executive Officer at ALCOA Inc. in New York, the United States. He received a Master degree in Economics and Business Administration from Georg-August-Universitaet Goettingen. He also holds a Doctorate in Philosophy degree in Strategic Management from Fachhochschule Wuerzburg-Schweinfurt.

Petra Kronen

Ms. Petra Kronen has been Member of the Supervisory Board at Bayer AG since July 2000. Additionally, she acts as Member of the Human Resources Committee of the Company. Ms. Kronen is active as Chairwoman of the Works Council of the Uerdingen site at Bayer AG. Moreover, she also serves as Vice Chairwoman of the Supervisory Board at Bayer MaterialScience AG as of December 7, 2009.

Helmut Panke

Dr. Helmut Gunter Wilhelm Panke, Ph.D., has been Member of the Supervisory Board at Bayer AG since April 27, 2007. He is former Chairman of the Board of Management of BMW AG, Munich. Dr. Panke serves on the Supervisory Board of Microsoft Corporation, Singapore Airlines Limited and UBS AG. He holds a Doctorate in Physics from Ludwig-Maximilians-Universitaet Muenchen.

Sue Rataj

Ms. Sue H. Rataj has been appointed Member of the Supervisory Board at Bayer AG with effect from April 27, 2012. She is Member of the Board of Directors at Cabot Corporation.

Petra Reinbold-Knape

Ms. Petra Reinbold-Knape has served as Member of the Supervisory Board of Bayer AG since April 27, 2012. She also acts as Northeast District Secretary of the German Mining, Chemical and Energy Industrial Union, and Member of the Supervisory Board at envia Mitteldeutsche Energie AG, Vattenfall Europe Genera tion AG, Vattenfall Europe Business Services GmbH (until May 2012), among others.

Michael Schmidt-Kiessling

Mr. Michael Schmidt-Kiessling has served as Member of the Supervisory Board of Bayer AG since April 27, 2012. He also is Vice Chairman of the Works Council of the Elberfeld site of Bayer and Member of the Supervisory Board at Bayer Pharma AG.

Ekkehard Schulz

Prof. Dr. Ekkehard D. Schulz has been Member of the Supervisory Board at Bayer AG since April 29, 2005. He is Member of the Audit Committee at the Company. He was Chairman of the Supervisory Board of ThyssenKrupp Services AG until September 30, 2009 and of ThyssenKrupp Technologies AG until October 11, 2009. Until January 2011, he served as Chairman of the Supervisory Board of ThyssenKrupp Elevator AG as well as ThyssenKrupp Steel Europe AG. He occupies the position of Chairman of the Executive Board at ThyssenKrupp AG. Dr. Schulz also serves as Member of the Supervisory Board at AXA Konzern AG and RWE AG. In addition, he acts as Vice Chairman of the Supervisory Board of MAN SE.

Klaus Sturany

Dr. Klaus Sturany has been Independent Member of the Supervisory Board at Bayer AG since April 27, 2007. Additionally, Dr. Sturany acts as Chairman of the Company's Audit Committee. He was Member of the Executive Board of RWE AG until April 30, 2007. Dr. Sturany was Member of the Supervisory Board of Commerzbank AG until May 15, 2008. He serves as Vice Chairman of the Supervisory Board of Hannover Rueckversicherung AG and as Member of the Supervisory Board at Heidelberger Druckmaschinen AG, Oesterreichische Industrieholding AG and Sulzer AG. He holds a Doctorate degree in Mathematics from Universitaet Innsbruck, which he gained in 1970, and holds a degree in Economics from Johannes Keppler Universitaet Linz.

Andre van Broich

Mr. Andre van Broich has served as Member of the Supervisory Board of Bayer AG since April 27, 2012. He also acts as Chairman of the Works Council of the Dormagen site of Bayer and Member of the Supervisory Board at Bayer CropScience AG.

Ernst-Ludwig Winnacker

Prof. Dr. Ernst-Ludwig Winnacker has been Member of the Supervisory Board at Bayer AG since April 1997. He is former President of the German Research Foundation in Bonn. In addition, he is Secretary General of the Human Frontier Science Program as of July 1, 2009. Furthermore, Prof. Dr. Winnacker acts as Member on the Supervisory Board of Wacker Chemie AG and occupies the position of Chairman of the Supervisory Board at Medigene AG.

Oliver Zuehlke

Mr. Oliver Zuehlke has been Member of the Supervisory Board at Bayer AG since April 27, 2007. Until December 30, 2008 he was Member of the Supervisory Board of Bayer HealthCare AG. Mr. Zuehlke is Chairman of the Works Council of the Leverkusen site of Bayer AG and is Chairman of the Bayer European Forum. He is Member of the Human Resources Committee at the Company.

Alexander Rosar

Basic Compensation

Search Stocks